Bioactive mesoporous silica materials-assisted cancer immunotherapy
- 25 October 2024
- journal article
- research article
- Published by Elsevier in Biomaterials
- Vol. 315, 122919
Abstract
No abstract availableKeywords
Funding Information
- Guangdong Provincial Natural Science Foundation (2024A1515010581)
- Basic and Applied Basic Research Foundation of Guangdong Province (2021A1515220001)
This publication has 150 references indexed in Scilit:
- An Engineered Nanoplatform with Tropism Toward Irradiated Glioblastoma Augments Its Radioimmunotherapy EfficacyAdvanced Materials, 2024
- Probiotic‐Inspired Nanomedicine Restores Intestinal Homeostasis in Colitis by Regulating Redox Balance, Immune Responses, and the Gut MicrobiomeAdvanced Materials, 2022
- Remodeling Tumor‐Associated Neutrophils to Enhance Dendritic Cell‐Based HCC Neoantigen Nano‐Vaccine EfficiencyAdvanced Science, 2022
- Tumor‐Microenvironment‐Responsive Nanomedicine for Enhanced Cancer ImmunotherapyAdvanced Science, 2021
- Near‐Infrared‐Light Remote‐Controlled Activation of Cancer Immunotherapy Using Photothermal Conjugated Polymer NanoparticlesAdvanced Materials, 2021
- A Versatile and Robust Platform for the Scalable Manufacture of Biomimetic NanovaccinesAdvanced Science, 2021
- Exogenous/Endogenous‐Triggered Mesoporous Silica Cancer NanomedicineAdvanced Healthcare Materials, 2018
- Nanoparticulate Delivery of Cancer Cell Membrane Elicits Multiantigenic Antitumor ImmunityAdvanced Materials, 2017
- Lymph Nodes and Lymphadenopathy in CancerJAMA Oncology, 2016
- MSN‐Mediated Sequential Vascular‐to‐Cell Nuclear‐Targeted Drug Delivery for Efficient Tumor RegressionAdvanced Materials, 2014